Lindbrook Capital, LLC Global Blood Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$32.4 - $68.18 $3,952 - $8,317	122 Added 244.0%	172 $12,000
Q2 2022 Aug 01, 2022	BUY	$22.3 - $37.39 $512 - $859	23 Added 85.19%	50 $2,000
Q1 2022 Apr 21, 2022	BUY	$25.68 - $35.59 $693 - $960	27 New	27 $1,000
Q2 2021 Jul 27, 2021	SELL	$32.46 - $43.42 $3,051 - $4,081	-94 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$38.94 - $50.85 $3,660 - $4,779	94 New	94 $4,000
Q4 2019 Jan 27, 2020	SELL	$45.7 - $81.86 $31,990 - $57,302	-700 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$45.35 - $57.91 $18,140 - $23,164	400 Added 133.33%	700 $34,000
Q2 2019 Jul 24, 2019	SELL	$52.6 - $63.29 $23,670 - $28,480	-450 Reduced 60.0%	300 $15,000
Q1 2019 Apr 23, 2019	SELL	$39.99 - $53.48 $23,994 - $32,087	-600 Reduced 44.44%	750 $39,000
Q4 2018 Feb 07, 2019	BUY	$31.54 - $46.67 $42,579 - $63,004	1,350 New	1,350 $55,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.